Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-002827
Filing Date
2022-03-10
Accepted
2022-03-10 14:55:22
Documents
2
Period of Report
2022-02-04

Document Format Files

Seq Description Document Type Size
1 form3-03102022_110300.html 3  
1 form3-03102022_110300.xml 3 1640
2 ex24-03102022_110306.htm EX-24 5854
  Complete submission text file 0001415889-22-002827.txt   8859
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA INC 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address
JACOBSON RACHEL (Reporting) CIK: 0001911725 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38365 | Film No.: 22728792